Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd. is a large drug retail chain enterprise in China, listed on the Shanghai Stock Exchange main board.
Last updated October 12, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Yifeng Pharmacy Chain Co., Ltd. is a large drug retail chain enterprise in China and a Shanghai Stock Exchange main board listed pharmacy chain. It was founded in June 2001 and focuses on the pharmaceutical retail industry. Its main business scope covers ten provinces and cities including Hunan, Hubei, Shanghai, Jiangsu, Jiangxi, Zhejiang, Guangdong, Hebei, Beijing, and Tianjin, with 14,831 chain pharmacies (including 4,313 franchise stores) and over 70,000 product SKUs as of December 31, 2025. As of the end of 2025, it had over 38,000 employees and 116 million members. In 2025, it achieved operating revenue of 24.433 billion yuan and net profit attributable to parent company of 1.678 billion yuan, a year-on-year increase of 9.81%.
History
Yifeng Pharmacy was founded in June 2001. In August 2003, it reformed its supply chain and created the 'customer, pharmaceutical factory, Yifeng' three-benefit business model. In August 2004, Yifeng Pharmacy Changsha Chaoyang store opened, marking successful cross-regional operation from northern Hunan to the whole province; in October 2004, Yifeng Pharmacy Shanghai Renmin Road store opened, becoming the largest single-store discount pharmacy in Shanghai, marking successful cross-province operation from central China to east China. In May 2006, Jiangsu Yifeng Pharmacy Chain Co., Ltd. was established, becoming the largest chain pharmacy in Jiangsu Province. In 2008, it entered Jiangxi Province, becoming the largest chain pharmacy in Jiangxi Province; in December 2008, it successfully signed with Capital Today. In 2009, it entered Zhejiang Province. In September 2011, the company was restructured into Yifeng Pharmacy Chain Co., Ltd.; in December 2011, it wholly acquired Shanghai Kaixinren Pharmacy. In March 2012, it officially launched new VI and SI. In October 2013, Yifeng Pharmacy e-commerce platform successfully launched. In February 2014, it won the 'China Pharmaceutical Retail Enterprise Operational Power Champion'. In February 2015, Yifeng Pharmacy Chain Co., Ltd. (603939) officially listed and traded, becoming the first listed retail chain pharmacy on China's Shanghai Stock Exchange main board. In February 2016, it successfully entered the Guangdong market through mergers and acquisitions. In May 2017, it ranked 11th on the '11th China Main Board Listed Companies Top 100 List'. In June 2018, it acquired Hebei leading chain pharmacy Xinxing Pharmacy for 1.384 billion yuan. In January 2019, it began building its industrial sector's own brand, Hengxiutang Pharmaceutical Co., Ltd. was established; in the same year, Yifeng Pharmacy sales exceeded 10 billion yuan. In June 2020, market value exceeded 50 billion yuan for the first time. In 2021, Yifeng Pharmacy celebrated its 20th anniversary. In October 2022, Yifeng Pharmacy's national stores exceeded 10,000. In April 2023, it released its strategic plan; in November 2023, it successfully issued convertible bonds, raising 1.797 billion yuan. In 2024, Yifeng Pharmacy's national stores exceeded 15,000. In October 2025, the Communist Party of China Yifeng Pharmacy Chain Co., Ltd. Committee was established.
- 2025
Communist Party Committee of Yifeng Pharmacy Chain Co., Ltd. established.
- 2024
National store count exceeded 15,000.
- 2023
Successfully issued convertible bonds, raising RMB 1.797 billion.
- 2022
National store count exceeded 10,000.
- 2021
Celebrated 20th anniversary; named to BrandZ Top 100 Most Valuable Chinese Brands.
- 2020
Market value exceeded RMB 50 billion for the first time.
- 2019
Hengxiutang Pharmaceutical Co., Ltd. established for digitalized TCM decoction pieces; sales exceeded RMB 10 billion.
- 2018
Acquired Hebei's leading chain Xinxing Pharmacy for RMB 1.384 billion, the largest acquisition in China's retail pharmacy history at the time.
- 2017
Ranked 11th on the 11th China Main Board Listed Companies Top 100 list.
- 2016
Entered Guangdong market through acquisition; set hundred-billion-yuan strategic goal.
Products and positioning
Committed to becoming a pharmacy that people can trust and rely on
Prescription drugs
Over-the-counter medicines
Traditional Chinese medicine decoction pieces
Health supplements
Medical devices
Personal care products
Chronic disease management services
Internet hospital services
Controversies
2023
2020
Shanghai Yifeng stores warned and ordered to correct unregistered mask sales
Shanghai's Hongkou District Market Supervision Administration ordered two Shanghai Yifeng Pharmacy stores to correct their failure to file the required online medical-device sales registration and issued warnings. The stores had sold unregistered disposable medical masks on Ele.me.
Recent events
- Unconfirmed
Shanghai Yifeng stores warned and ordered to correct unregistered mask sales[5]
Reported:
Shanghai's Hongkou District Market Supervision Administration ordered two Shanghai Yifeng Pharmacy stores to correct their failure to file the required online medical-device sales registration and issued warnings. The stores had sold unregistered disposable medical masks on Ele.me.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/益丰药房 · Editorial policy · How profiles are compiled